Stewart Factor, DO
Neurology · Atlanta, GANPI 1942316815
Payments from drug & device makers
Across 268 payments — averaging $3768.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$618K
- Amneal Pharmaceuticals LLC$200K
- Sunovion Pharmaceuticals Inc.$76K
- Eli Lilly$49K
- Acorda Therapeutics, Inc$18K
- Biohaven Pharmaceutical Holding Company Ltd.$17K
- plus $32K from 9 others
Across 2 payments — averaging $13,132 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$26K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 133 | $618,016 |
| Amneal Pharmaceuticals LLC | 45 | $200,165 |
| Sunovion Pharmaceuticals Inc. | 44 | $75,897 |
| Eli Lilly | 4 | $48,963 |
| Acorda Therapeutics, Inc | 7 | $17,987 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $17,080 |
| Jazz Pharmaceuticals Inc. | 5 | $15,532 |
| Lundbeck LLC | 7 | $7,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $6,000 |
| Acadia Pharmaceuticals Inc | 1 | $1,800 |
| Teva Pharmaceuticals USA, Inc. | 6 | $1,132 |
| Biohaven Pharmaceuticals, Inc. | 3 | $210 |
| W. L. Gore & Associates, Inc. | 1 | $41 |
| GE HealthCare | 2 | $40 |
| AbbVie | 1 | $24 |
How this compares
$1,009,887 in reported general payments places this provider in the 95th percentile of 506 neurology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Atlanta
- James LahAtlanta$6.8M
- Jonathan GlassAtlanta$5.1M
- Allan LeveyAtlanta$4.2M
- Ben ThrowerAtlanta$3.7M
- Jeffrey EnglishAtlanta$3.1M
- Dennis LaceyAtlanta$2.8M
- Julio FlaminiAtlanta$1.6M
- Joash LazarusAtlanta$1.4M
- Frank BerensonAtlanta$1.2M
- Matthews GwynnAtlanta$775K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.